| |
| |
|
| Insider
Information: |
Rogers Dawn |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
31,923 |
|
|
Indirect Shares
|
9,818 |
|
|
| Direct
Value |
$666,672 |
|
|
|
Indirect Value
|
$249,377 |
|
|
| Total
Shares |
41,741 |
|
|
| Total
Value |
$916,049 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Executive Vice President |
2020-04-29 |
4,823 |
2020-04-29 |
9,818 |
Premium* |
|
|
DXC Technology Co |
DXC |
Director |
2023-08-07 |
27,100 |
2021-04-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXC |
DXC Technology Co |
Director |
– • – |
2023-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
27,100 |
0 |
- |
|
| DXC |
DXC Technology Co |
Director |
– • – |
2022-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,300 |
14,700 |
0 |
- |
|
| DXC |
DXC Technology Co |
Director |
– • – |
2021-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
8,400 |
0 |
- |
|
| DXC |
DXC Technology Co |
Director |
– • – |
2021-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,800 |
2,800 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-04-29 |
4 |
S |
$38.13 |
$495,690 |
D/D |
(13,000) |
4,823 |
0 |
% |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$436,359 |
D/D |
(12,222) |
17,823 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
OE |
$27.37 |
$487,843 |
D/D |
17,824 |
30,045 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$467,483 |
D/D |
(12,774) |
12,221 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
OE |
$34.59 |
$522,205 |
D/D |
15,097 |
24,995 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-23 |
4 |
D |
$35.72 |
$36,256 |
D/D |
(1,015) |
9,898 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-04-29 |
4 |
D |
$39.59 |
$168,455 |
D/D |
(4,255) |
10,665 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-03-04 |
4 |
S |
$42.98 |
$644,798 |
D/D |
(15,002) |
14,920 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$642,014 |
D/D |
(15,127) |
34,865 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,943 |
49,992 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$621,942 |
D/D |
19,297 |
45,049 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-25 |
4 |
D |
$43.08 |
$53,118 |
D/D |
(1,233) |
25,752 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
D |
$41.91 |
$451,346 |
D/D |
(10,653) |
26,985 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
OE |
$21.03 |
$405,669 |
D/D |
19,290 |
37,638 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
